Clay Capital β Full Portfolio
6 tracked investments Β· listed companies and verified rows first
A bio-pharmaceutical and real estate holding company that conducts cannabis genomic research through its subsidiaries to develop improved cannabis and hemp strains for medical and industrial applications, while maintaining agricultural licenses and significant real estate holdings.
Tucson, US
Glenn E Martin(Director and Chief Executive Officer)Nicole M Breen(Director, Secretary and Treasurer)inPatrick E Williams(Director)
Co-investorsFulcrum Global Capital
Infinite Roots cultivates mycelium (mushroom roots) via liquid fermentation using natural side streams such as brewers' spent grain, turning it into protein-, fiber-, and vitamin-rich culinary ingredients.
BiotechCircular EconomyClimate TechFoodTechHamburg, DE
Mazen
Co-investorsFoodLabsJoyance PartnersSimon CapitalUnruly CapitalHappiness Capitalredalpine
Scindo uses AI and machine learning to discover and design novel enzymes for sustainable manufacturing.
AI & Machine LearningBiotechCleantech
Co-investorsFarvatn VentureSynBioVenAgFunderKadmos CapitalPINCSOSV
WeedOUT develops a biological herbicide using proprietary sterile weed pollen to control resistant weeds in agriculture.
AgTechBiotech
Efrat Lidor Nili(Founder)in
Co-investorsFulcrum Global CapitalRadicle GrowthZORA
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
NxtFood (ACCRO)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.